State bans on conversion therapy remain enforceable after the US Supreme Court’s ruling, but experts warn the decision may invite new legal challenges.

A novel mu-opioid receptor agonist showed strong analgesia without respiratory depression, tolerance, or significant ...

Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.

"I find the consistency across age, race, BMI, and glycemic status more clinically exciting than the sex difference," said ...

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect ...

Dr Chu-Yueh Guo prepares to discover how the latest diagnostic criteria and breakthrough treatments are reshaping the ...

Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security.

In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is ...

In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK ...

Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking ...

Early survival results from the first stage of a phase 3 study suggest that gotistobart, a new antibody associated with anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), has potential as a ...

Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.